KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Ann: Novogen Announces Outcome of Comprehensive Science Review, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Merchant2000
    21,923 Posts.
    lightbulb Created with Sketch. 899
    clock Created with Sketch.
    31/08/15
    09:01
    Post #: 15902997
    Fully agree that there is nothing new

    Less emphasis on jacobs hope program

    Cantrixil, Anisina, aiming for human trials at some point in 2016

    ​
    Trilexium (TRXE-009) human trials by 2017

    IMO, the excitement and constant flow of news around the CR led many to believe that human trials were much closer than the company has anticipated



    DYOR

    New CEO hopefully appointed by years end
    Last edited by Merchant2000: 31/08/15
    NRT Price at posting: 15.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Trump is President Again: What Does This Mean for Crypto?
right-arrow Created with Sketch.
RMX Red Mountain Mining (ASX:RMX) announces Bonanza Grade Gold Results at Flicka Lake
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
NEWS Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
right-arrow Created with Sketch.
NEWS HotCopper Highlights: Your most watched and most discussed stocks this week
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.